+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

miRNA Sequencing And Assay Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 To 2031

  • PDF Icon

    Report

  • 117 Pages
  • October 2023
  • Region: Global
  • Acute Market Reports
  • ID: 5910299
Description Jump to:
miRNA, or microRNA, are small non-coding RNAs that play a vital role in the regulation of gene expression. The miRNA sequencing and assay market market revolves around the technologies and methodologies employed to study these RNA molecules, which have been linked to various disease mechanisms and are often the subject of innovative therapeutic research. miRNA sequencing and assay market market is estimated to grow at a CAGR of 13.1% from 2023 to 2031, driven by increasing significance in cancer research and technological advancements in RNA sequencing.

Increasing Significance in Cancer Research

One of the most robust drivers propelling the miRNA sequencing and assay market market is its growing significance in cancer research. miRNAs are increasingly recognized as pivotal players in tumorigenesis and cancer progression. For example, miR-21 and miR-155 have been regularly implicated in various forms of cancer, including breast and lung cancer. Evidence supporting this comes from numerous clinical samples and studies, wherein altered miRNA expressions were detected in tumor tissues as compared to normal tissues. Additionally, miRNAs like miR-34a have shown potential as therapeutic agents, opening new avenues in cancer therapeutics.

Role in Diagnostic Biomarkers

Another significant growth driver is the potential of miRNA as diagnostic biomarkers. Diseases often induce changes in miRNA expression profiles. In many cases, these changes can be detected even before the disease manifests any noticeable symptoms. An instance supporting this is the elevation of certain miRNAs in the blood samples of patients suffering from cardiovascular ailments or specific types of tumors. Such evidence indicates that miRNA sequencing can be a reliable tool for early disease detection, rendering it invaluable in preventative medicine.

Technological Advancements in RNA Sequencing

Technological advancements have consistently bolstered the miRNA sequencing and assay market market. Enhanced accuracy, increased throughput, and reduced costs are some benefits reaped from these advancements. A case in point is the emergence of Next Generation Sequencing (NGS), which offers superior sensitivity and specificity in detecting low abundance miRNAs. These advancements have not only streamlined the sequencing process but have also expanded its applicability in diverse research settings.

High Costs and Technical Challenges

However, the miRNA sequencing and assay market market faces significant restraints, primarily stemming from the high costs and technical challenges associated with these assays. MiRNA sequencing is a meticulous process, requiring high degrees of precision and expertise. Even minor discrepancies can lead to data misinterpretations. For instance, the presence of isomiRs, or miRNA variants, can confound sequencing results. Furthermore, while technologies like NGS have reduced sequencing costs over the years, they remain prohibitive for many labs, especially those in resource-limited settings. These challenges, if unaddressed, might hamper the adoption and utility of miRNA sequencing in broader research and clinical settings.

Market Segmentation

The miRNA sequencing and assay market Market in 2022 demonstrated a strong inclination towards advanced sequencing technologies and optimized workflows, with geographic variances influencing market dynamics. For the forecast period of 2023 to 2031, the market is expected to undergo substantial shifts owing to technological advancements, improved workflows, and regional growth opportunities.

Sequencing By Synthesis (SBS) Technology Leads the Market

By 2022, in terms of technology, Sequencing By Synthesis (SBS) registered the highest revenue. SBS's popularity emanated from its ability to analyze millions of sequences concurrently, making it a preferred choice for various applications, especially large-scale genomic projects. However, Nanopore Sequencing is projected to showcase the highest CAGR from 2023 to 2031. This is attributed to its ability to deliver real-time sequencing data without the need for fragmenting the DNA, combined with reduced costs and increasing commercial availability. SOLiD, once lauded for its high throughput and accuracy, witnessed reduced traction due to the complexity of its technical aspects. While the Sanger Sequencing method, renowned for its high accuracy, saw steady usage in specific research areas, its lower throughput as compared to newer methods limited its revenue potential. Single Molecule Real-time (SMRT) Sequencing, though powerful, primarily appealed to niche sectors of the market due to its distinct advantages in detecting base modifications.

Sequencing Workflow Remains as The Dominant Segment in Revenue Terms

Regarding workflow, 2022 saw Sequencing as the dominant segment in revenue terms, primarily because of the substantial costs associated with high-throughput sequencing technologies. Library Preparation followed closely, given the crucial role it plays in ensuring the quality of sequenced data. Data Analysis & Storage, though integral, garnered lesser revenue due to the availability of open-source tools and cloud storage solutions. From 2023 to 2031, Data Analysis & Storage is expected to witness the highest CAGR as big data analytics becomes central to deriving meaningful insights from sequencing data, and as labs increasingly invest in sophisticated data solutions.

North America Leads the Market

Geographically, North America, with its advanced healthcare infrastructure and significant investments in research, commanded the highest revenue percentage in 2022. Europe followed suit, buoyed by its collaborative research environment and robust funding mechanisms. However, the Asia-Pacific region is projected to exhibit the highest CAGR from 2023 to 2031, propelled by increasing investments in genomics research, growing awareness, and improving healthcare infrastructure, particularly in countries like China and India.

Competitive Trends

On the competitive front, the miRNA sequencing and assay market Market was characterized by strategic collaborations, mergers, and innovations. Top players like Illumina, Inc., Thermo Fisher Scientific, and QIAGEN were at the forefront, driving technological advancements and expanding their geographic reach. A key strategy among market leaders was the development of integrated solutions encompassing all stages of the miRNA sequencing workflow, from library preparation to data analysis. Moreover, to solidify their market presence, companies frequently engaged in partnerships with research institutions and other stakeholders. Key Players include Thermo Fisher Scientific, Inc., Illumina, Inc., QIAGEN, PerkinElmer, Inc., Abcam plc, New England Biolabs, Takara Bio Inc., Lexogen GmbH, NorgenBiotek Corp., MaravaiLifeSciences, HTG Molecular Diagnostics, Inc., Meridian Bioscience, Inc., System Biosciences, LLC.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of miRNA Sequencing And Assay market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the miRNA Sequencing And Assay market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product & Service

  • Product
  • Library Preparation Kits
  • Sequencing Consumables
  • Instruments
  • Service

Technology

  • Sequencing By Synthesis
  • Sequencing By Oligonucleotide Ligation and Detection (SOLiD)
  • Nanopore Sequencing
  • Sanger Sequencing.
  • Single Molecule Real-time (SMRT) Sequencing

Workflow

  • Library Preparation
  • Sequencing
  • Data Analysis & Storage

Application

  • Cancer
  • Polyglutamine Diseases
  • Autoimmune Disease
  • Schizophrenia
  • Others

End-Use

  • Pharmaceutical & Biotechnology Industry
  • Research and Academic Institutes
  • Others

Region Segment (2021 - 2031; US$ Million)

  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of miRNA Sequencing And Assay market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the miRNA Sequencing And Assay market?
  • Which is the largest regional market for miRNA Sequencing And Assay market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving miRNA Sequencing And Assay market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the miRNA Sequencing And Assay market worldwide?


This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global miRNA Sequencing And Assay Market
2.2. Global miRNA Sequencing And Assay Market, By Product & Service, 2022 (US$ Million)
2.3. Global miRNA Sequencing And Assay Market, By Technology, 2022 (US$ Million)
2.4. Global miRNA Sequencing And Assay Market, By Workflow, 2022 (US$ Million)
2.5. Global miRNA Sequencing And Assay Market, By Application, 2022 (US$ Million)
2.6. Global miRNA Sequencing And Assay Market, By End-Use, 2022 (US$ Million)
2.7. Global miRNA Sequencing And Assay Market, By Geography, 2022 (US$ Million)
2.8. Attractive Investment Proposition by Geography, 2022
3. miRNA Sequencing And Assay Market: Competitive Analysis
3.1. Market Positioning of Key miRNA Sequencing And Assay Market Vendors
3.2. Strategies Adopted by miRNA Sequencing And Assay Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031
4. miRNA Sequencing And Assay Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global miRNA Sequencing And Assay Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
5. miRNA Sequencing And Assay Market: By Product & Service, 2021-2031, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
5.3.1. Product
5.3.1.1. Library Preparation Kits
5.3.1.2. Sequencing Consumables
5.3.1.3. Instruments
5.3.2. Service
6. miRNA Sequencing And Assay Market: By Technology, 2021-2031, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
6.3.1. Sequencing By Synthesis
6.3.2. Sequencing By Oligonucleotide Ligation and Detection (SOLiD)
6.3.3. Nanopore Sequencing
6.3.4. Sanger Sequencing.
6.3.5. Single Molecule Real-time (SMRT) Sequencing
7. miRNA Sequencing And Assay Market: By Workflow, 2021-2031, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2022 Versus 2031
7.3. Market Segmentation
7.3.1. Library Preparation
7.3.2. Sequencing
7.3.3. Data Analysis & Storage
8. miRNA Sequencing And Assay Market: By Application, 2021-2031, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2022 Versus 2031
8.3. Market Segmentation
8.3.1. Cancer
8.3.2. Polyglutamine Diseases
8.3.3. Autoimmune Disease
8.3.4. Schizophrenia
8.3.5. Others
9. miRNA Sequencing And Assay Market: By End-Use, 2021-2031, USD (Million)
9.1. Market Overview
9.2. Growth & Revenue Analysis: 2022 Versus 2031
9.3. Market Segmentation
9.3.1. Pharmaceutical & Biotechnology Industry
9.3.2. Research and Academic Institutes
9.3.3. Others
10. North America miRNA Sequencing And Assay Market, 2021-2031, USD (Million)
10.1. Market Overview
10.2. miRNA Sequencing And Assay Market: By Product & Service, 2021-2031, USD (Million)
10.3. miRNA Sequencing And Assay Market: By Technology, 2021-2031, USD (Million)
10.4. miRNA Sequencing And Assay Market: By Workflow, 2021-2031, USD (Million)
10.5. miRNA Sequencing And Assay Market: By Application, 2021-2031, USD (Million)
10.6. miRNA Sequencing And Assay Market: By End-Use, 2021-2031, USD (Million)
10.7.miRNA Sequencing And Assay Market: By Region, 2021-2031, USD (Million)
10.7.1.North America
10.7.1.1. U.S.
10.7.1.1.1. miRNA Sequencing And Assay Market: By Product & Service, 2021-2031, USD (Million)
10.7.1.1.2. miRNA Sequencing And Assay Market: By Technology, 2021-2031, USD (Million)
10.7.1.1.3. miRNA Sequencing And Assay Market: By Workflow, 2021-2031, USD (Million)
10.7.1.1.4. miRNA Sequencing And Assay Market: By Application, 2021-2031, USD (Million)
10.7.1.1.5. miRNA Sequencing And Assay Market: By End-Use, 2021-2031, USD (Million)
10.7.1.2. Canada
10.7.1.2.1. miRNA Sequencing And Assay Market: By Product & Service, 2021-2031, USD (Million)
10.7.1.2.2. miRNA Sequencing And Assay Market: By Technology, 2021-2031, USD (Million)
10.7.1.2.3. miRNA Sequencing And Assay Market: By Workflow, 2021-2031, USD (Million)
10.7.1.2.4. miRNA Sequencing And Assay Market: By Application, 2021-2031, USD (Million)
10.7.1.2.5. miRNA Sequencing And Assay Market: By End-Use, 2021-2031, USD (Million)
10.7.1.3. Rest of North America
10.7.1.3.1. miRNA Sequencing And Assay Market: By Product & Service, 2021-2031, USD (Million)
10.7.1.3.2. miRNA Sequencing And Assay Market: By Technology, 2021-2031, USD (Million)
10.7.1.3.3. miRNA Sequencing And Assay Market: By Workflow, 2021-2031, USD (Million)
10.7.1.3.4. miRNA Sequencing And Assay Market: By Application, 2021-2031, USD (Million)
10.7.1.3.5. miRNA Sequencing And Assay Market: By End-Use, 2021-2031, USD (Million)
11. UK and European Union miRNA Sequencing And Assay Market, 2021-2031, USD (Million)
11.1. Market Overview
11.2. miRNA Sequencing And Assay Market: By Product & Service, 2021-2031, USD (Million)
11.3. miRNA Sequencing And Assay Market: By Technology, 2021-2031, USD (Million)
11.4. miRNA Sequencing And Assay Market: By Workflow, 2021-2031, USD (Million)
11.5. miRNA Sequencing And Assay Market: By Application, 2021-2031, USD (Million)
11.6. miRNA Sequencing And Assay Market: By End-Use, 2021-2031, USD (Million)
11.7.miRNA Sequencing And Assay Market: By Region, 2021-2031, USD (Million)
11.7.1.UK and European Union
11.7.1.1. UK
11.7.1.1.1. miRNA Sequencing And Assay Market: By Product & Service, 2021-2031, USD (Million)
11.7.1.1.2. miRNA Sequencing And Assay Market: By Technology, 2021-2031, USD (Million)
11.7.1.1.3. miRNA Sequencing And Assay Market: By Workflow, 2021-2031, USD (Million)
11.7.1.1.4. miRNA Sequencing And Assay Market: By Application, 2021-2031, USD (Million)
11.7.1.1.5. miRNA Sequencing And Assay Market: By End-Use, 2021-2031, USD (Million)
11.7.1.2. Germany
11.7.1.2.1. miRNA Sequencing And Assay Market: By Product & Service, 2021-2031, USD (Million)
11.7.1.2.2. miRNA Sequencing And Assay Market: By Technology, 2021-2031, USD (Million)
11.7.1.2.3. miRNA Sequencing And Assay Market: By Workflow, 2021-2031, USD (Million)
11.7.1.2.4. miRNA Sequencing And Assay Market: By Application, 2021-2031, USD (Million)
11.7.1.2.5. miRNA Sequencing And Assay Market: By End-Use, 2021-2031, USD (Million)
11.7.1.3. Spain
11.7.1.3.1. miRNA Sequencing And Assay Market: By Product & Service, 2021-2031, USD (Million)
11.7.1.3.2. miRNA Sequencing And Assay Market: By Technology, 2021-2031, USD (Million)
11.7.1.3.3. miRNA Sequencing And Assay Market: By Workflow, 2021-2031, USD (Million)
11.7.1.3.4. miRNA Sequencing And Assay Market: By Application, 2021-2031, USD (Million)
11.7.1.3.5. miRNA Sequencing And Assay Market: By End-Use, 2021-2031, USD (Million)
11.7.1.4. Italy
11.7.1.4.1. miRNA Sequencing And Assay Market: By Product & Service, 2021-2031, USD (Million)
11.7.1.4.2. miRNA Sequencing And Assay Market: By Technology, 2021-2031, USD (Million)
11.7.1.4.3. miRNA Sequencing And Assay Market: By Workflow, 2021-2031, USD (Million)
11.7.1.4.4. miRNA Sequencing And Assay Market: By Application, 2021-2031, USD (Million)
11.7.1.4.5. miRNA Sequencing And Assay Market: By End-Use, 2021-2031, USD (Million)
11.7.1.5. France
11.7.1.5.1. miRNA Sequencing And Assay Market: By Product & Service, 2021-2031, USD (Million)
11.7.1.5.2. miRNA Sequencing And Assay Market: By Technology, 2021-2031, USD (Million)
11.7.1.5.3. miRNA Sequencing And Assay Market: By Workflow, 2021-2031, USD (Million)
11.7.1.5.4. miRNA Sequencing And Assay Market: By Application, 2021-2031, USD (Million)
11.7.1.5.5. miRNA Sequencing And Assay Market: By End-Use, 2021-2031, USD (Million)
11.7.1.6. Rest of Europe
11.7.1.6.1. miRNA Sequencing And Assay Market: By Product & Service, 2021-2031, USD (Million)
11.7.1.6.2. miRNA Sequencing And Assay Market: By Technology, 2021-2031, USD (Million)
11.7.1.6.3. miRNA Sequencing And Assay Market: By Workflow, 2021-2031, USD (Million)
11.7.1.6.4. miRNA Sequencing And Assay Market: By Application, 2021-2031, USD (Million)
11.7.1.6.5. miRNA Sequencing And Assay Market: By End-Use, 2021-2031, USD (Million)
12. Asia Pacific miRNA Sequencing And Assay Market, 2021-2031, USD (Million)
12.1. Market Overview
12.2. miRNA Sequencing And Assay Market: By Product & Service, 2021-2031, USD (Million)
12.3. miRNA Sequencing And Assay Market: By Technology, 2021-2031, USD (Million)
12.4. miRNA Sequencing And Assay Market: By Workflow, 2021-2031, USD (Million)
12.5. miRNA Sequencing And Assay Market: By Application, 2021-2031, USD (Million)
12.6. miRNA Sequencing And Assay Market: By End-Use, 2021-2031, USD (Million)
12.7.miRNA Sequencing And Assay Market: By Region, 2021-2031, USD (Million)
12.7.1.Asia Pacific
12.7.1.1. China
12.7.1.1.1. miRNA Sequencing And Assay Market: By Product & Service, 2021-2031, USD (Million)
12.7.1.1.2. miRNA Sequencing And Assay Market: By Technology, 2021-2031, USD (Million)
12.7.1.1.3. miRNA Sequencing And Assay Market: By Workflow, 2021-2031, USD (Million)
12.7.1.1.4. miRNA Sequencing And Assay Market: By Application, 2021-2031, USD (Million)
12.7.1.1.5. miRNA Sequencing And Assay Market: By End-Use, 2021-2031, USD (Million)
12.7.1.2. Japan
12.7.1.2.1. miRNA Sequencing And Assay Market: By Product & Service, 2021-2031, USD (Million)
12.7.1.2.2. miRNA Sequencing And Assay Market: By Technology, 2021-2031, USD (Million)
12.7.1.2.3. miRNA Sequencing And Assay Market: By Workflow, 2021-2031, USD (Million)
12.7.1.2.4. miRNA Sequencing And Assay Market: By Application, 2021-2031, USD (Million)
12.7.1.2.5. miRNA Sequencing And Assay Market: By End-Use, 2021-2031, USD (Million)
12.7.1.3. India
12.7.1.3.1. miRNA Sequencing And Assay Market: By Product & Service, 2021-2031, USD (Million)
12.7.1.3.2. miRNA Sequencing And Assay Market: By Technology, 2021-2031, USD (Million)
12.7.1.3.3. miRNA Sequencing And Assay Market: By Workflow, 2021-2031, USD (Million)
12.7.1.3.4. miRNA Sequencing And Assay Market: By Application, 2021-2031, USD (Million)
12.7.1.3.5. miRNA Sequencing And Assay Market: By End-Use, 2021-2031, USD (Million)
12.7.1.4. Australia
12.7.1.4.1. miRNA Sequencing And Assay Market: By Product & Service, 2021-2031, USD (Million)
12.7.1.4.2. miRNA Sequencing And Assay Market: By Technology, 2021-2031, USD (Million)
12.7.1.4.3. miRNA Sequencing And Assay Market: By Workflow, 2021-2031, USD (Million)
12.7.1.4.4. miRNA Sequencing And Assay Market: By Application, 2021-2031, USD (Million)
12.7.1.4.5. miRNA Sequencing And Assay Market: By End-Use, 2021-2031, USD (Million)
12.7.1.5. South Korea
12.7.1.5.1. miRNA Sequencing And Assay Market: By Product & Service, 2021-2031, USD (Million)
12.7.1.5.2. miRNA Sequencing And Assay Market: By Technology, 2021-2031, USD (Million)
12.7.1.5.3. miRNA Sequencing And Assay Market: By Workflow, 2021-2031, USD (Million)
12.7.1.5.4. miRNA Sequencing And Assay Market: By Application, 2021-2031, USD (Million)
12.7.1.5.5. miRNA Sequencing And Assay Market: By End-Use, 2021-2031, USD (Million)
12.7.1.6. Rest of Asia Pacific
12.7.1.6.1. miRNA Sequencing And Assay Market: By Product & Service, 2021-2031, USD (Million)
12.7.1.6.2. miRNA Sequencing And Assay Market: By Technology, 2021-2031, USD (Million)
12.7.1.6.3. miRNA Sequencing And Assay Market: By Workflow, 2021-2031, USD (Million)
12.7.1.6.4. miRNA Sequencing And Assay Market: By Application, 2021-2031, USD (Million)
12.7.1.6.5. miRNA Sequencing And Assay Market: By End-Use, 2021-2031, USD (Million)
13. Latin America miRNA Sequencing And Assay Market, 2021-2031, USD (Million)
13.1. Market Overview
13.2. miRNA Sequencing And Assay Market: By Product & Service, 2021-2031, USD (Million)
13.3. miRNA Sequencing And Assay Market: By Technology, 2021-2031, USD (Million)
13.4. miRNA Sequencing And Assay Market: By Workflow, 2021-2031, USD (Million)
13.5. miRNA Sequencing And Assay Market: By Application, 2021-2031, USD (Million)
13.6. miRNA Sequencing And Assay Market: By End-Use, 2021-2031, USD (Million)
13.7.miRNA Sequencing And Assay Market: By Region, 2021-2031, USD (Million)
13.7.1.Latin America
13.7.1.1. Brazil
13.7.1.1.1. miRNA Sequencing And Assay Market: By Product & Service, 2021-2031, USD (Million)
13.7.1.1.2. miRNA Sequencing And Assay Market: By Technology, 2021-2031, USD (Million)
13.7.1.1.3. miRNA Sequencing And Assay Market: By Workflow, 2021-2031, USD (Million)
13.7.1.1.4. miRNA Sequencing And Assay Market: By Application, 2021-2031, USD (Million)
13.7.1.1.5. miRNA Sequencing And Assay Market: By End-Use, 2021-2031, USD (Million)
13.7.1.2. Mexico
13.7.1.2.1. miRNA Sequencing And Assay Market: By Product & Service, 2021-2031, USD (Million)
13.7.1.2.2. miRNA Sequencing And Assay Market: By Technology, 2021-2031, USD (Million)
13.7.1.2.3. miRNA Sequencing And Assay Market: By Workflow, 2021-2031, USD (Million)
13.7.1.2.4. miRNA Sequencing And Assay Market: By Application, 2021-2031, USD (Million)
13.7.1.2.5. miRNA Sequencing And Assay Market: By End-Use, 2021-2031, USD (Million)
13.7.1.3. Rest of Latin America
13.7.1.3.1. miRNA Sequencing And Assay Market: By Product & Service, 2021-2031, USD (Million)
13.7.1.3.2. miRNA Sequencing And Assay Market: By Technology, 2021-2031, USD (Million)
13.7.1.3.3. miRNA Sequencing And Assay Market: By Workflow, 2021-2031, USD (Million)
13.7.1.3.4. miRNA Sequencing And Assay Market: By Application, 2021-2031, USD (Million)
13.7.1.3.5. miRNA Sequencing And Assay Market: By End-Use, 2021-2031, USD (Million)
14. Middle East and Africa miRNA Sequencing And Assay Market, 2021-2031, USD (Million)
14.1. Market Overview
14.2. miRNA Sequencing And Assay Market: By Product & Service, 2021-2031, USD (Million)
14.3. miRNA Sequencing And Assay Market: By Technology, 2021-2031, USD (Million)
14.4. miRNA Sequencing And Assay Market: By Workflow, 2021-2031, USD (Million)
14.5. miRNA Sequencing And Assay Market: By Application, 2021-2031, USD (Million)
14.6. miRNA Sequencing And Assay Market: By End-Use, 2021-2031, USD (Million)
14.7.miRNA Sequencing And Assay Market: By Region, 2021-2031, USD (Million)
14.7.1.Middle East and Africa
14.7.1.1. GCC
14.7.1.1.1. miRNA Sequencing And Assay Market: By Product & Service, 2021-2031, USD (Million)
14.7.1.1.2. miRNA Sequencing And Assay Market: By Technology, 2021-2031, USD (Million)
14.7.1.1.3. miRNA Sequencing And Assay Market: By Workflow, 2021-2031, USD (Million)
14.7.1.1.4. miRNA Sequencing And Assay Market: By Application, 2021-2031, USD (Million)
14.7.1.1.5. miRNA Sequencing And Assay Market: By End-Use, 2021-2031, USD (Million)
14.7.1.2. Africa
14.7.1.2.1. miRNA Sequencing And Assay Market: By Product & Service, 2021-2031, USD (Million)
14.7.1.2.2. miRNA Sequencing And Assay Market: By Technology, 2021-2031, USD (Million)
14.7.1.2.3. miRNA Sequencing And Assay Market: By Workflow, 2021-2031, USD (Million)
14.7.1.2.4. miRNA Sequencing And Assay Market: By Application, 2021-2031, USD (Million)
14.7.1.2.5. miRNA Sequencing And Assay Market: By End-Use, 2021-2031, USD (Million)
14.7.1.3. Rest of Middle East and Africa
14.7.1.3.1. miRNA Sequencing And Assay Market: By Product & Service, 2021-2031, USD (Million)
14.7.1.3.2. miRNA Sequencing And Assay Market: By Technology, 2021-2031, USD (Million)
14.7.1.3.3. miRNA Sequencing And Assay Market: By Workflow, 2021-2031, USD (Million)
14.7.1.3.4. miRNA Sequencing And Assay Market: By Application, 2021-2031, USD (Million)
14.7.1.3.5. miRNA Sequencing And Assay Market: By End-Use, 2021-2031, USD (Million)
15. Company Profile
15.1. Thermo Fisher Scientific, Inc.
15.1.1. Company Overview
15.1.2. Financial Performance
15.1.3. Product Portfolio
15.1.4. Strategic Initiatives
15.2. Illumina, Inc.
15.2.1. Company Overview
15.2.2. Financial Performance
15.2.3. Product Portfolio
15.2.4. Strategic Initiatives
15.3. QIAGEN
15.3.1. Company Overview
15.3.2. Financial Performance
15.3.3. Product Portfolio
15.3.4. Strategic Initiatives
15.4. PerkinElmer, Inc.
15.4.1. Company Overview
15.4.2. Financial Performance
15.4.3. Product Portfolio
15.4.4. Strategic Initiatives
15.5. Abcam plc
15.5.1. Company Overview
15.5.2. Financial Performance
15.5.3. Product Portfolio
15.5.4. Strategic Initiatives
15.6. New England Biolabs
15.6.1. Company Overview
15.6.2. Financial Performance
15.6.3. Product Portfolio
15.6.4. Strategic Initiatives
15.7. Takara Bio Inc.
15.7.1. Company Overview
15.7.2. Financial Performance
15.7.3. Product Portfolio
15.7.4. Strategic Initiatives
15.8. Lexogen GmbH
15.8.1. Company Overview
15.8.2. Financial Performance
15.8.3. Product Portfolio
15.8.4. Strategic Initiatives
15.9. NorgenBiotek Corp.
15.9.1. Company Overview
15.9.2. Financial Performance
15.9.3. Product Portfolio
15.9.4. Strategic Initiatives
15.10. MaravaiLifeSciences
15.10.1. Company Overview
15.10.2. Financial Performance
15.10.3. Product Portfolio
15.10.4. Strategic Initiatives
15.11. HTG Molecular Diagnostics, Inc.
15.11.1. Company Overview
15.11.2. Financial Performance
15.11.3. Product Portfolio
15.11.4. Strategic Initiatives
15.12. Meridian Bioscience, Inc.
15.12.1. Company Overview
15.12.2. Financial Performance
15.12.3. Product Portfolio
15.12.4. Strategic Initiatives
15.13. System Biosciences, LLC.
15.13.1. Company Overview
15.13.2. Financial Performance
15.13.3. Product Portfolio
15.13.4. Strategic Initiatives
15.14. Other Notable Players
15.14.1. Company Overview
15.14.2. Financial Performance
15.14.3. Product Portfolio
15.14.4. Strategic Initiatives
List of Figures
FIG. 1 Global miRNA Sequencing And Assay Market: Market Coverage
FIG. 2 Research Methodology and Data Sources
FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
FIG. 4 Global miRNA Sequencing And Assay Market: Quality Assurance
FIG. 5 Global miRNA Sequencing And Assay Market, By Product & Service, 2022
FIG. 6 Global miRNA Sequencing And Assay Market, By Technology, 2022
FIG. 7 Global miRNA Sequencing And Assay Market, By Workflow, 2022
FIG. 8 Global miRNA Sequencing And Assay Market, By Application, 2022
FIG. 9 Global miRNA Sequencing And Assay Market, By End-Use, 2022
FIG. 10 Global miRNA Sequencing And Assay Market, By Geography, 2022
FIG. 11 Market Geographical Opportunity Matrix - Global miRNA Sequencing And Assay Market, 2022
FIG. 12 Market Positioning of Key miRNA Sequencing And Assay Market Players, 2022
FIG. 13 Global miRNA Sequencing And Assay Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
FIG. 14 Global miRNA Sequencing And Assay Market, By Product & Service, 2022 Vs 2031, %
FIG. 15 Global miRNA Sequencing And Assay Market, By Technology, 2022 Vs 2031, %
FIG. 16 Global miRNA Sequencing And Assay Market, By Workflow, 2022 Vs 2031, %
FIG. 17 Global miRNA Sequencing And Assay Market, By Application, 2022 Vs 2031, %
FIG. 18 Global miRNA Sequencing And Assay Market, By End-Use, 2022 Vs 2031, %
FIG. 19 U.S. miRNA Sequencing And Assay Market (US$ Million), 2021 - 2031
FIG. 20 Canada miRNA Sequencing And Assay Market (US$ Million), 2021 - 2031
FIG. 21 Rest of North America miRNA Sequencing And Assay Market (US$ Million), 2021 - 2031
FIG. 22 UK miRNA Sequencing And Assay Market (US$ Million), 2021 - 2031
FIG. 23 Germany miRNA Sequencing And Assay Market (US$ Million), 2021 - 2031
FIG. 24 Spain miRNA Sequencing And Assay Market (US$ Million), 2021 - 2031
FIG. 25 Italy miRNA Sequencing And Assay Market (US$ Million), 2021 - 2031
FIG. 26 France miRNA Sequencing And Assay Market (US$ Million), 2021 - 2031
FIG. 27 Rest of Europe miRNA Sequencing And Assay Market (US$ Million), 2021 - 2031
FIG. 28 China miRNA Sequencing And Assay Market (US$ Million), 2021 - 2031
FIG. 29 Japan miRNA Sequencing And Assay Market (US$ Million), 2021 - 2031
FIG. 30 India miRNA Sequencing And Assay Market (US$ Million), 2021 - 2031
FIG. 31 Australia miRNA Sequencing And Assay Market (US$ Million), 2021 - 2031
FIG. 32 South Korea miRNA Sequencing And Assay Market (US$ Million), 2021 - 2031
FIG. 33 Rest of Asia miRNA Sequencing And Assay Market (US$ Million), 2021 - 2031
FIG. 34 Brazil miRNA Sequencing And Assay Market (US$ Million), 2021 - 2031
FIG. 35 Mexico miRNA Sequencing And Assay Market (US$ Million), 2021 - 2031
FIG. 36 Rest of Latin America miRNA Sequencing And Assay Market (US$ Million), 2021 - 2031
FIG. 37 GCC miRNA Sequencing And Assay Market (US$ Million), 2021 - 2031
FIG. 38 Africa miRNA Sequencing And Assay Market (US$ Million), 2021 - 2031
FIG. 39 Rest of Middle East and Africa miRNA Sequencing And Assay Market (US$ Million), 2021 - 2031
List of Tables
TABLE 1 Global miRNA Sequencing And Assay Market By Product & Service, 2021-2031, USD (Million)
TABLE 2 Global miRNA Sequencing And Assay Market By Product, 2021-2031, USD (Million)
TABLE 3 Global miRNA Sequencing And Assay Market By Technology, 2021-2031, USD (Million)
TABLE 4 Global miRNA Sequencing And Assay Market By Workflow, 2021-2031, USD (Million)
TABLE 5 Global miRNA Sequencing And Assay Market By Application, 2021-2031, USD (Million)
TABLE 6 Global miRNA Sequencing And Assay Market By End-Use, 2021-2031, USD (Million)
TABLE 7 North America miRNA Sequencing And Assay Market By Product & Service, 2021-2031, USD (Million)
TABLE 8 North America miRNA Sequencing And Assay Market By Product, 2021-2031, USD (Million)
TABLE 9 North America miRNA Sequencing And Assay Market By Technology, 2021-2031, USD (Million)
TABLE 10 North America miRNA Sequencing And Assay Market By Workflow, 2021-2031, USD (Million)
TABLE 11 North America miRNA Sequencing And Assay Market By Application, 2021-2031, USD (Million)
TABLE 12 North America miRNA Sequencing And Assay Market By End-Use, 2021-2031, USD (Million)
TABLE 13 U.S. miRNA Sequencing And Assay Market By Product & Service, 2021-2031, USD (Million)
TABLE 14 U.S. miRNA Sequencing And Assay Market By Product, 2021-2031, USD (Million)
TABLE 15 U.S. miRNA Sequencing And Assay Market By Technology, 2021-2031, USD (Million)
TABLE 16 U.S. miRNA Sequencing And Assay Market By Workflow, 2021-2031, USD (Million)
TABLE 17 U.S. miRNA Sequencing And Assay Market By Application, 2021-2031, USD (Million)
TABLE 18 U.S. miRNA Sequencing And Assay Market By End-Use, 2021-2031, USD (Million)
TABLE 19 Canada miRNA Sequencing And Assay Market By Product & Service, 2021-2031, USD (Million)
TABLE 20 Canada miRNA Sequencing And Assay Market By Product, 2021-2031, USD (Million)
TABLE 21 Canada miRNA Sequencing And Assay Market By Technology, 2021-2031, USD (Million)
TABLE 22 Canada miRNA Sequencing And Assay Market By Workflow, 2021-2031, USD (Million)
TABLE 23 Canada miRNA Sequencing And Assay Market By Application, 2021-2031, USD (Million)
TABLE 24 Canada miRNA Sequencing And Assay Market By End-Use, 2021-2031, USD (Million)
TABLE 25 Rest of North America miRNA Sequencing And Assay Market By Product & Service, 2021-2031, USD (Million)
TABLE 26 Rest of North America miRNA Sequencing And Assay Market By Product, 2021-2031, USD (Million)
TABLE 27 Rest of North America miRNA Sequencing And Assay Market By Technology, 2021-2031, USD (Million)
TABLE 28 Rest of North America miRNA Sequencing And Assay Market By Workflow, 2021-2031, USD (Million)
TABLE 29 Rest of North America miRNA Sequencing And Assay Market By Application, 2021-2031, USD (Million)
TABLE 30 Rest of North America miRNA Sequencing And Assay Market By End-Use, 2021-2031, USD (Million)
TABLE 31 UK and European Union miRNA Sequencing And Assay Market By Product & Service, 2021-2031, USD (Million)
TABLE 32 UK and European Union miRNA Sequencing And Assay Market By Product, 2021-2031, USD (Million)
TABLE 33 UK and European Union miRNA Sequencing And Assay Market By Technology, 2021-2031, USD (Million)
TABLE 34 UK and European Union miRNA Sequencing And Assay Market By Workflow, 2021-2031, USD (Million)
TABLE 35 UK and European Union miRNA Sequencing And Assay Market By Application, 2021-2031, USD (Million)
TABLE 36 UK and European Union miRNA Sequencing And Assay Market By End-Use, 2021-2031, USD (Million)
TABLE 37 UK miRNA Sequencing And Assay Market By Product & Service, 2021-2031, USD (Million)
TABLE 38 UK miRNA Sequencing And Assay Market By Product, 2021-2031, USD (Million)
TABLE 39 UK miRNA Sequencing And Assay Market By Technology, 2021-2031, USD (Million)
TABLE 40 UK miRNA Sequencing And Assay Market By Workflow, 2021-2031, USD (Million)
TABLE 41 UK miRNA Sequencing And Assay Market By Application, 2021-2031, USD (Million)
TABLE 42 UK miRNA Sequencing And Assay Market By End-Use, 2021-2031, USD (Million)
TABLE 43 Germany miRNA Sequencing And Assay Market By Product & Service, 2021-2031, USD (Million)
TABLE 44 Germany miRNA Sequencing And Assay Market By Product, 2021-2031, USD (Million)
TABLE 45 Germany miRNA Sequencing And Assay Market By Technology, 2021-2031, USD (Million)
TABLE 46 Germany miRNA Sequencing And Assay Market By Workflow, 2021-2031, USD (Million)
TABLE 47 Germany miRNA Sequencing And Assay Market By Application, 2021-2031, USD (Million)
TABLE 48 Germany miRNA Sequencing And Assay Market By End-Use, 2021-2031, USD (Million)
TABLE 49 Spain miRNA Sequencing And Assay Market By Product & Service, 2021-2031, USD (Million)
TABLE 50 Spain miRNA Sequencing And Assay Market By Product, 2021-2031, USD (Million)
TABLE 51 Spain miRNA Sequencing And Assay Market By Technology, 2021-2031, USD (Million)
TABLE 52 Spain miRNA Sequencing And Assay Market By Workflow, 2021-2031, USD (Million)
TABLE 53 Spain miRNA Sequencing And Assay Market By Application, 2021-2031, USD (Million)
TABLE 54 Spain miRNA Sequencing And Assay Market By End-Use, 2021-2031, USD (Million)
TABLE 55 Italy miRNA Sequencing And Assay Market By Product & Service, 2021-2031, USD (Million)
TABLE 56 Italy miRNA Sequencing And Assay Market By Product, 2021-2031, USD (Million)
TABLE 57 Italy miRNA Sequencing And Assay Market By Technology, 2021-2031, USD (Million)
TABLE 58 Italy miRNA Sequencing And Assay Market By Workflow, 2021-2031, USD (Million)
TABLE 59 Italy miRNA Sequencing And Assay Market By Application, 2021-2031, USD (Million)
TABLE 60 Italy miRNA Sequencing And Assay Market By End-Use, 2021-2031, USD (Million)
TABLE 61 France miRNA Sequencing And Assay Market By Product & Service, 2021-2031, USD (Million)
TABLE 62 France miRNA Sequencing And Assay Market By Product, 2021-2031, USD (Million)
TABLE 63 France miRNA Sequencing And Assay Market By Technology, 2021-2031, USD (Million)
TABLE 64 France miRNA Sequencing And Assay Market By Workflow, 2021-2031, USD (Million)
TABLE 65 France miRNA Sequencing And Assay Market By Application, 2021-2031, USD (Million)
TABLE 66 France miRNA Sequencing And Assay Market By End-Use, 2021-2031, USD (Million)
TABLE 67 Rest of Europe miRNA Sequencing And Assay Market By Product & Service, 2021-2031, USD (Million)
TABLE 68 Rest of Europe miRNA Sequencing And Assay Market By Product, 2021-2031, USD (Million)
TABLE 69 Rest of Europe miRNA Sequencing And Assay Market By Technology, 2021-2031, USD (Million)
TABLE 70 Rest of Europe miRNA Sequencing And Assay Market By Workflow, 2021-2031, USD (Million)
TABLE 71 Rest of Europe miRNA Sequencing And Assay Market By Application, 2021-2031, USD (Million)
TABLE 72 Rest of Europe miRNA Sequencing And Assay Market By End-Use, 2021-2031, USD (Million)
TABLE 73 Asia miRNA Sequencing And Assay Market By Product & Service, 2021-2031, USD (Million)
TABLE 74 Asia miRNA Sequencing And Assay Market By Product, 2021-2031, USD (Million)
TABLE 75 Asia miRNA Sequencing And Assay Market By Technology, 2021-2031, USD (Million)
TABLE 76 Asia miRNA Sequencing And Assay Market By Workflow, 2021-2031, USD (Million)
TABLE 77 Asia miRNA Sequencing And Assay Market By Application, 2021-2031, USD (Million)
TABLE 78 Asia miRNA Sequencing And Assay Market By End-Use, 2021-2031, USD (Million)
TABLE 79 China miRNA Sequencing And Assay Market By Product & Service, 2021-2031, USD (Million)
TABLE 80 China miRNA Sequencing And Assay Market By Product, 2021-2031, USD (Million)
TABLE 81 China miRNA Sequencing And Assay Market By Technology, 2021-2031, USD (Million)
TABLE 82 China miRNA Sequencing And Assay Market By Workflow, 2021-2031, USD (Million)
TABLE 83 China miRNA Sequencing And Assay Market By Application, 2021-2031, USD (Million)
TABLE 84 China miRNA Sequencing And Assay Market By End-Use, 2021-2031, USD (Million)
TABLE 85 Japan miRNA Sequencing And Assay Market By Product & Service, 2021-2031, USD (Million)
TABLE 86 Japan miRNA Sequencing And Assay Market By Product, 2021-2031, USD (Million)
TABLE 87 Japan miRNA Sequencing And Assay Market By Technology, 2021-2031, USD (Million)
TABLE 88 Japan miRNA Sequencing And Assay Market By Workflow, 2021-2031, USD (Million)
TABLE 89 Japan miRNA Sequencing And Assay Market By Application, 2021-2031, USD (Million)
TABLE 90 Japan miRNA Sequencing And Assay Market By End-Use, 2021-2031, USD (Million)
TABLE 91 India miRNA Sequencing And Assay Market By Product & Service, 2021-2031, USD (Million)
TABLE 92 India miRNA Sequencing And Assay Market By Product, 2021-2031, USD (Million)
TABLE 93 India miRNA Sequencing And Assay Market By Technology, 2021-2031, USD (Million)
TABLE 94 India miRNA Sequencing And Assay Market By Workflow, 2021-2031, USD (Million)
TABLE 95 India miRNA Sequencing And Assay Market By Application, 2021-2031, USD (Million)
TABLE 96 India miRNA Sequencing And Assay Market By End-Use, 2021-2031, USD (Million)
TABLE 97 Australia miRNA Sequencing And Assay Market By Product & Service, 2021-2031, USD (Million)
TABLE 98 Australia miRNA Sequencing And Assay Market By Product, 2021-2031, USD (Million)
TABLE 99 Australia miRNA Sequencing And Assay Market By Technology, 2021-2031, USD (Million)
TABLE 100 Australia miRNA Sequencing And Assay Market By Workflow, 2021-2031, USD (Million)
TABLE 101 Australia miRNA Sequencing And Assay Market By Application, 2021-2031, USD (Million)
TABLE 102 Australia miRNA Sequencing And Assay Market By End-Use, 2021-2031, USD (Million)
TABLE 103 South Korea miRNA Sequencing And Assay Market By Product & Service, 2021-2031, USD (Million)
TABLE 104 South Korea miRNA Sequencing And Assay Market By Product, 2021-2031, USD (Million)
TABLE 105 South Korea miRNA Sequencing And Assay Market By Technology, 2021-2031, USD (Million)
TABLE 106 South Korea miRNA Sequencing And Assay Market By Workflow, 2021-2031, USD (Million)
TABLE 107 South Korea miRNA Sequencing And Assay Market By Application, 2021-2031, USD (Million)
TABLE 108 South Korea miRNA Sequencing And Assay Market By End-Use, 2021-2031, USD (Million)
TABLE 109 Latin America miRNA Sequencing And Assay Market By Product & Service, 2021-2031, USD (Million)
TABLE 110 Latin America miRNA Sequencing And Assay Market By Product, 2021-2031, USD (Million)
TABLE 111 Latin America miRNA Sequencing And Assay Market By Technology, 2021-2031, USD (Million)
TABLE 112 Latin America miRNA Sequencing And Assay Market By Workflow, 2021-2031, USD (Million)
TABLE 113 Latin America miRNA Sequencing And Assay Market By Application, 2021-2031, USD (Million)
TABLE 114 Latin America miRNA Sequencing And Assay Market By End-Use, 2021-2031, USD (Million)
TABLE 115 Brazil miRNA Sequencing And Assay Market By Product & Service, 2021-2031, USD (Million)
TABLE 116 Brazil miRNA Sequencing And Assay Market By Product, 2021-2031, USD (Million)
TABLE 117 Brazil miRNA Sequencing And Assay Market By Technology, 2021-2031, USD (Million)
TABLE 118 Brazil miRNA Sequencing And Assay Market By Workflow, 2021-2031, USD (Million)
TABLE 119 Brazil miRNA Sequencing And Assay Market By Application, 2021-2031, USD (Million)
TABLE 120 Brazil miRNA Sequencing And Assay Market By End-Use, 2021-2031, USD (Million)
TABLE 121 Mexico miRNA Sequencing And Assay Market By Product & Service, 2021-2031, USD (Million)
TABLE 122 Mexico miRNA Sequencing And Assay Market By Product, 2021-2031, USD (Million)
TABLE 123 Mexico miRNA Sequencing And Assay Market By Technology, 2021-2031, USD (Million)
TABLE 124 Mexico miRNA Sequencing And Assay Market By Workflow, 2021-2031, USD (Million)
TABLE 125 Mexico miRNA Sequencing And Assay Market By Application, 2021-2031, USD (Million)
TABLE 126 Mexico miRNA Sequencing And Assay Market By End-Use, 2021-2031, USD (Million)
TABLE 127 Rest of Latin America miRNA Sequencing And Assay Market By Product & Service, 2021-2031, USD (Million)
TABLE 128 Rest of Latin America miRNA Sequencing And Assay Market By Product, 2021-2031, USD (Million)
TABLE 129 Rest of Latin America miRNA Sequencing And Assay Market By Technology, 2021-2031, USD (Million)
TABLE 130 Rest of Latin America miRNA Sequencing And Assay Market By Workflow, 2021-2031, USD (Million)
TABLE 131 Rest of Latin America miRNA Sequencing And Assay Market By Application, 2021-2031, USD (Million)
TABLE 132 Rest of Latin America miRNA Sequencing And Assay Market By End-Use, 2021-2031, USD (Million)
TABLE 133 Middle East and Africa miRNA Sequencing And Assay Market By Product & Service, 2021-2031, USD (Million)
TABLE 134 Middle East and Africa miRNA Sequencing And Assay Market By Product, 2021-2031, USD (Million)
TABLE 135 Middle East and Africa miRNA Sequencing And Assay Market By Technology, 2021-2031, USD (Million)
TABLE 136 Middle East and Africa miRNA Sequencing And Assay Market By Workflow, 2021-2031, USD (Million)
TABLE 137 Middle East and Africa miRNA Sequencing And Assay Market By Application, 2021-2031, USD (Million)
TABLE 138 Middle East and Africa miRNA Sequencing And Assay Market By End-Use, 2021-2031, USD (Million)
TABLE 139 GCC miRNA Sequencing And Assay Market By Product & Service, 2021-2031, USD (Million)
TABLE 140 GCC miRNA Sequencing And Assay Market By Product, 2021-2031, USD (Million)
TABLE 141 GCC miRNA Sequencing And Assay Market By Technology, 2021-2031, USD (Million)
TABLE 142 GCC miRNA Sequencing And Assay Market By Workflow, 2021-2031, USD (Million)
TABLE 143 GCC miRNA Sequencing And Assay Market By Application, 2021-2031, USD (Million)
TABLE 144 GCC miRNA Sequencing And Assay Market By End-Use, 2021-2031, USD (Million)
TABLE 145 Africa miRNA Sequencing And Assay Market By Product & Service, 2021-2031, USD (Million)
TABLE 146 Africa miRNA Sequencing And Assay Market By Product, 2021-2031, USD (Million)
TABLE 147 Africa miRNA Sequencing And Assay Market By Technology, 2021-2031, USD (Million)
TABLE 148 Africa miRNA Sequencing And Assay Market By Workflow, 2021-2031, USD (Million)
TABLE 149 Africa miRNA Sequencing And Assay Market By Application, 2021-2031, USD (Million)
TABLE 150 Africa miRNA Sequencing And Assay Market By End-Use, 2021-2031, USD (Million)
TABLE 151 Rest of Middle East and Africa miRNA Sequencing And Assay Market By Product & Service, 2021-2031, USD (Million)
TABLE 152 Rest of Middle East and Africa miRNA Sequencing And Assay Market By Product, 2021-2031, USD (Million)
TABLE 153 Rest of Middle East and Africa miRNA Sequencing And Assay Market By Technology, 2021-2031, USD (Million)
TABLE 154 Rest of Middle East and Africa miRNA Sequencing And Assay Market By Workflow, 2021-2031, USD (Million)
TABLE 155 Rest of Middle East and Africa miRNA Sequencing And Assay Market By Application, 2021-2031, USD (Million)
TABLE 156 Rest of Middle East and Africa miRNA Sequencing And Assay Market By End-Use, 2021-2031, USD (Million)

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • QIAGEN
  • PerkinElmer, Inc.
  • Abcam plc
  • New England Biolabs
  • Takara Bio Inc.
  • Lexogen GmbH
  • NorgenBiotek Corp.
  • MaravaiLifeSciences
  • HTG Molecular Diagnostics, Inc.
  • Meridian Bioscience, Inc.
  • System Biosciences, LLC.

Related Topics

Related Reports

miRNA Sequencing and Assay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

miRNA Sequencing and Assay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 250 Pages
  • Global
miRNA Sequencing & Assay Market by Product & Service, Technology, Workflow, End-User, Application - Global Forecast 2025-2030 - Product Image

miRNA Sequencing & Assay Market by Product & Service, Technology, Workflow, End-User, Application - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
MiRNA Sequencing and Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

MiRNA Sequencing and Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 185 Pages
  • Global
From
MicroRNA Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

MicroRNA Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 273 Pages
  • Global
MicroRNA Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

MicroRNA Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 183 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.